Clinical Epigenetics

Aims & Scope

Encompassing the broad spectrum of epigenetics research from basic research to innovations in therapeutic treatments, Clinical Epigenetics is a top tier, open access journal devoted to the study of epigenetic principles and mechanisms as applied to human development, disease, diagnosis and treatment.

The journal particularly welcomes submissions involving clinical trials, translational research, new and innovative methodologies and model organisms providing mechanistic insights.

The journal is divided into the following sections: Aging and development epigenetics Allergy, immunology, and pathogen epigenetics Cancer epigenetics and diagnostics Cardiovascular epigenetics Endocrinology and metabolic epigenetics Environmental epigenetics Epigenetic biomarkers Epigenetic technologies Epigenetic drugs and clinical trials Innovative therapies Lifestyle epigenetics Neurology and psychiatry epigenetics Regenerative medicine Reproductive and transgenerational epigenetics

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.4
2024	4.80

Journal Rank

Year	Value
2024	1689

Journal Citation Indicator

Year	Value
2024	3081

SJR (SCImago Journal Rank)

Year	Value
2024	1.833

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	86

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• PubMed
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Statistical predictions with glmnet

  Citation: 822

  Authors: Solveig, Jon

• The role and mechanisms of action of microRNAs in cancer drug resistance

  Citation: 560

  Authors: Wengong, Jiaying, Huilin, Weimin

• Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort

  Citation: 478

  Authors: Laura, Yan, Ute, Bernd, Kai-Uwe, Hermann

• Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage

  Citation: 446

  Authors: Hao, Ran, Junjie, Zelian, Lixiang

• Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors

  Citation: 415

  Authors: Geneviève P, Dilshad H, James R

• Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy

  Citation: 339

  Authors: Ludovica, Michael, Manfred

• DNA methylation changes of whole blood cells in response to active smoking exposure in adults: a systematic review of DNA methylation studies

  Citation: 335

  Authors: Xu, Min, Yan, Lutz Philipp, Hermann

• Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

  Citation: 326

  Authors: Julia M., Björn, Michael, Manfred

• Sirtuin functions and modulation: from chemistry to the clinic

  Citation: 319

  Authors: Vincenzo, Dante, Mariantonietta, Francesca, Enrica, Gebremedhin Solomon, Elina, Maija, Antonello, Lucia

• The epigenetic effects of butyrate: potential therapeutic implications for clinical practice

  Citation: 318

  Authors: Roberto, Margherita, Ludovica

---